Skip to main content

People in the News: Jun 22, 2010


Scott Greer has been appointed chairman of the board of directors of Ablexis, an antibody technology company.

Greer founded and served as CEO and later as chairman of the board of Abgenix, until its acquisition by Amgen in 2006. He also served as chairman of the board of Sirna Therapeutics before its $1.1 billion acquisition by Merck in 2007. In the past, Greer has served on several other boards, including Affymax and Illumina. He is currently the managing director of Numenor Ventures.

Sequenom has elected several members to its board of directors who will serve until 2011, including: Ernst-Günter Afting; Kenneth Buechler; John Fazio; Harry Hixson; Richard Lerner; Ronald Lindsay; and David Pendarvis.

The Scan

Gap in COVAX Doses

BBC News reports that COVAX is experiencing a vaccine shortfall, as the Serum Institute of India has paused exports.

Sanofi, GSK Report Promising Results

The Wall Street Journal reports that the candidate SARS-CoV-2 vaccine from Sanofi and GlaxoSmithKline has had encouraging early results.

Influence of Luck

The New York Times examines how the US avoided variant-fueled increases in COVID-19 cases.

PLOS Papers on Retina GWAS, Hantaan Virus, COVID-19 Phenome-Wide Association Study

In PLOS this week: genome-wide association study of retinal morphology, analysis of hantaan virus found in a mouse, and more.